In addition, associations between genetic variation in the GSK-3 gene and schizophrenia (SZ) have been reported (Li et al., 2011; Blasi et al., 2013; Tang et al., 2013) and a number of other susceptibility genes for SZ, including the genes encoding for the proteins disrupted in SZ (DISC1), neuregulin 1 (NRG-1), and dysbindin converge on GSK-3 signaling (Numakawa et al., 2004; Clapcote et al., 2007; Keri et al., 2009; Mao et al., 2009; Guo et al., 2010; Seres et al., 2010; Lipina et al., 2011, 2012). The gene discussed is NRG1; the disease is schizophrenia.